photo walkheader_zpsd5bunpmi.png

Monthly Archives: October 2013

Microwave “Surgery” for Pancreatic Cancer

Studies involving the thermal (heating) mode for the treatment of pancreatic cancer (ductal adenocarcinoma of the pancreas) have generally concentrated on radio waves. This form of “surgery” is called ablation – and of course is not surgery at all, but the destruction of tumor tissue by heating it to levels that cause cell death.  Generally, the […]

Clinical Trial Results with Votrient for Advanced Neuroendocrine Tumors

Votrient (pazopanib) is a drug-agent of GlaxoSmithKline that appears to work through targeting angiogenesis and growth pathways, and has been approved for use in renal cell carcinoma and advanced soft tissue sarcoma, and now is under study for use in neuroendocrine tumors. Two other recent targeted agents that have been approved by the U.S. FDA […]

A Setback for ARBs for the Treatment of Pancreatic Cancer?

Again, for more than a decade there have been theoretical discussions about the use of drugs commonly used to treat high blood pressure for use in the treatment of cancer – pancreatic cancer (ductal adenocarcinoma of the pancreas). And having just published a Pancreatica blog entry based on the pre-clinical study and work by Jain […]

Facebook
Facebook